Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 214,445,382 papers from all fields of science
Search
Sign In
Create Free Account
MACOP-B regimen
Known as:
Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen
A regimen consisting of methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine and prednisone, used to treat aggressive forms of non…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Broader (6)
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Cyclophosphamide
Methotrexate
Expand
Doxorubicin
Leucovorin Calcium
Lymphoma, Non-Hodgkin
Prednisone
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.
S. Bernstein
,
J. Unger
,
M. LeBlanc
,
J. Friedberg
,
T. Miller
,
R. Fisher
Journal of Clinical Oncology
2009
Corpus ID: 23259330
PURPOSE To investigate the incidence, natural history, and risk factors predictive of CNS relapse in patients with de novo…
Expand
Review
2004
Review
2004
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma.
A. Ferreri
,
E. Campo
,
+24 authors
M. Ponzoni
Annals of Oncology
2004
Corpus ID: 6758369
BACKGROUND Optimal therapeutic management of intravascular lymphoma (IVL) lacks precise guidelines. PATIENTS AND METHODS The…
Expand
Highly Cited
2004
Highly Cited
2004
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients
P. Zinzani
,
S. Fanti
,
+12 authors
M. Baccarani
British Journal of Cancer
2004
Corpus ID: 1565845
An extensive analysis of the reliability of positron emission tomography (PET) after induction treatment in patients with Hodgkin…
Expand
Highly Cited
1997
Highly Cited
1997
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
A. Gianni
,
M. Bregni
,
+9 authors
G. Bonadonna
New England Journal of Medicine
1997
Corpus ID: 2415184
BACKGROUND We compared a regimen of six chemotherapeutic agents administered sequentially at high doses, followed by…
Expand
Highly Cited
1993
Highly Cited
1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
R. Fisher
,
E. Gaynor
,
+6 authors
T. Miller
New England Journal of Medicine
1993
Corpus ID: 45482792
BACKGROUND CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine…
Expand
Highly Cited
1993
Highly Cited
1993
Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.
M. Lazzarino
,
E. Orlandi
,
+7 authors
M. C. Buonanno
Journal of Clinical Oncology
1993
Corpus ID: 7973853
PURPOSE To evaluate the clinical features of presentation, the morphologic and immunohistochemical pattern, the modality of…
Expand
Highly Cited
1991
Highly Cited
1991
Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B.
P. Hoskins
,
V. Ng
,
J. Spinelli
,
P. Klimo
,
J. Connors
Journal of Clinical Oncology
1991
Corpus ID: 13516262
One hundred twenty-six patients with diffuse large-cell lymphoma were treated with methotrexate with leucovorin, doxorubicin…
Expand
Highly Cited
1990
Highly Cited
1990
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.
L. Kwak
,
J. Halpern
,
R. Olshen
,
S. Horning
Journal of Clinical Oncology
1990
Corpus ID: 13501066
While diffuse large-cell lymphoma (DLCL) is considered to be highly curable with current therapy, treatment failures are observed…
Expand
Highly Cited
1988
Highly Cited
1988
MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations.
J. Connors
,
P. Klimo
Seminars in hematology (Print)
1988
Corpus ID: 37289643
Between 1981 and 1986, we treated 179 newly diagnosed patients with advanced-stage malignant lymphoma or related conditions with…
Expand
Highly Cited
1985
Highly Cited
1985
MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma.
P. Klimo
,
J. Connors
Annals of Internal Medicine
1985
Corpus ID: 41888421
Between April 1981 and May 1984, 61 patients with advanced diffuse large-cell lymphoma completed treatment with MACOP-B…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE